AI
Angiex, Inc.
SEC filingBiotechnology · Cambridge, MA
Amount raised$22Msold at filing
Total offering$28.4M$6.4M still open
Investors in the raise137count reported to the SEC
FiledSep 26, 2025first sale Jul 31, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Jonathan AdamsDirector
Errik AndersonDirector
Jason CammDirector
Fabian HansenDirector
Paul JaminetExecutive Officer, Director
Amal AminDirector
Haijing GuoDirector
Iain DukesDirector
Tina NeelDirector
Executive officers, directors and promoters as listed on the Form D.